Inactive Instrument

InVitro International Stock price Other OTC

Equities

IVRO

US4618531036

Pharmaceuticals

Sales 2022 854K Sales 2023 793K Capitalization 1.3M
Net income 2022 - Net income 2023 - EV / Sales 2022 0.29 x
Net cash position 2022 1.23M Net cash position 2023 1.13M EV / Sales 2023 0.22 x
P/E ratio 2022
69.3 x
P/E ratio 2023
885 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 96.73%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 19-09-14
Director of Finance/CFO - 19-09-14
President - 19-06-02
Members of the board TitleAgeSince
Director/Board Member 89 20-09-22
Director/Board Member - -
Chief Executive Officer - 19-09-14
More insiders
InVitro International, Inc. is a customer and technology-driven provider of non-animal testing methods. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. The Company produces and sells in vitro assay kits to detect, rank and predict the potential level of irritancy, toxicity or corrosivity of substances on human eye (ocular) and/or skin tissue (dermal). It sells its products direct to customers, independent partner laboratories, and agents in the United States, Europe, Latin America and Asia. It also sells vitro products, which include Ocular Irritection, which is used to evaluate the potential for ocular irritation; Irritection Dermal, which is used to evaluate the potential for dermal irritation and Corrositex, which is used to determine corrosivity level classifications. It also conducts laboratory testing for those customers who prefer not to conduct their own tests.
More about the company
  1. Stock
  2. Equities
  3. Stock InVitro International
  4. Stock InVitro International - Other OTC